Tissue doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after Iron replacement therapy

Echocardiography

Volumn 29, Issue 1, 2012, Pages 13-18

  Gaber, Rania ^a   Kotb, Nesreen A ^a   Ghazy, Medhat ^a   Nagy, Hala M ^a   Salama, Mai ^a   Elhendy, Abdou ^b  

^a TANTA UNIVERSITY   (Egypt)

^b MARSHFIELD CLINIC   (United States)

Author keywords

congestive heart failure; iron deficiency; tissue Doppler imaging

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FERRITIN; HEMOGLOBIN; IRON DEXTRAN; SPIRONOLACTONE; TRANSFERRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; FUNCTIONAL STATUS; HEART EJECTION FRACTION; HEART FUNCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; IRON THERAPY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; STRAIN GAUGE TRANSDUCER; SYSTOLE; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; VELOCITY; WALKING;

ANEMIA, IRON-DEFICIENCY; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEART FAILURE; HUMANS; IRON; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84856020755     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2011.01532.x     Document Type: Article

References (36)

1. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53 (15): e1-e90.
2. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933-989.
3. Jessup M, Brozena S,: Heart failure. N Engl J Med 2003; 348: 2007-2018.
4. Véronique L, Susan A, Margaret M, et al,: Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344-350.
5. Clark AL, Poole-Wilson PA, Coats AJ,: Exercise limitation in chronic heart failure: Central role of the periphery. J Am Coll Cardiol 1996; 28: 1092-1102. (Pubitemid 26376979)
6. Massie BM, Conway M, Rajagopalan B, et al,: Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: Evidence for abnormalities unrelated to blood flow. Circulation 1988; 78: 320-326.
7. Dunn LL, Armando YS, Richardson DR,: Iron uptake and metabolism in the new millennium. Trends Cell Boil 2007; 17: 93-100. (Pubitemid 46199183)
8. Fairbanks V, Butler E,: Iron deficiency. In:, Butler E, (ed): Williamhematology. 6th Ed. New York: McGraw-Hill, 2001, pp. 447-470.
9. Blayney L, Bailey-Wood R, Jacobs A, et al,: The effects of iron deficiency on the respiratory function and cytochrome content of rat heart mitochondria. Cir Res 1976; 39: 744-748.
10. Opasich C, Cazzola M, Scelsi L, et al,: Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anemia in patients with chronic heart failure. Eur Heart J 2005; 26: 2232-2237. (Pubitemid 41541385)
11. Nanas JN, Matsouka C, Karageorgopoulos D, et al,: Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006; 48: 2485-2489. (Pubitemid 44881220)
12. Miyatake K, Yamagishi M, Tanaka N, et al,: New method for evolution of left ventricular wall motion by color-coded tissue Doppler imaging: In vitro and in vivo studies. J Am Coll Cardiol 1995; 25: 717-724.
13. Duzenli MA, Ozdemir K, Aygul N,: Relationship between systolic myocardial velocity obtained by tissue Doppler imaging and left ventricular ejection fraction: Systolic myocardial velocity predicts the degreeof left ventricular dysfunction in heart failure. Echocardiography 2008; 25: 856-63.
14. Groban L, Sanders DM, Houle TT, et al,: Prognostic value of tissue Doppler-Derived E/e' on early morbid events after cardiac surgery. Echocardiography 2010; 27: 131-138.
15. American Society of Echocardiography, Committee on Standards. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 338-367.
16. Oh JK, Seward JB, Tajik J,: Assessment of diastolic function. In:, Oh JK, (ed). The Echo Manual. 2nd Ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 1999, pp. 45-57.
17. Yesildag O, Koprulu D, Yuksel S, et al,: Noninvasive assessment of left ventricular end-diastolic pressure with tissue Doppler imaging in patients with mitral regurgitation. Echocardiography 2011; 28: 633-640.
18. Tumuklu MM, Etikan I, Cinar CS,: Left ventricular function in professional football players evaluated by tissue Doppler imaging and strain imaging. Int J Cardiovasc Imaging 2008; 24 (1): 25-35. (Pubitemid 350263100)
19. Leung DY, Ng AC,: Emerging clinical role of strain imaging in echocardiography. Heart Lung Circ 2010; 19: 161-174.
20. Kiotsekoglou A, Saha S, Moggridge JC, et al,: Impaired biventricular deformation in Marfan syndrome: a strain and strain rate study in adult unoperated patients. Echocardiography 2011; 28: 416-430.
21. Voigt JU, Arnold MF, Karlsson M, et al,: Assessment of regional longitudinal myocardial strain rate derived from Doppler myocardial imaging indexes in normal and infarcted myocardium. J Am Soc Echocardiogr 2000; 13: 588-598. (Pubitemid 30418895)
22. Edvardsen T, Gerber BL, Garot J, et al,: Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: Validation against three-dimensional tagged magnetic resonance imaging. Circulation 2002; 106: 50-56. (Pubitemid 34747441)
23. Ganzoni AM,: Intravenous iron-dextran: Therapeutic and experimental possibilities. Schweiz Med Wochenschr 1970; 100: 301-303.
24. Jacobs A, Worwood M,: Ferritinin in serum: Clinical and biochemical implications. N Engl J Med 1975; 292-951.
25. Ramsy WNM,: Test combination iron binding capacity. Adv Clin Chem 1958; 1: 1.
26. Beard JL,: Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 2001; 131 (Suppl 2): 568S-579S.
27. Haas JD, Brownlie T,: IV. Iron deficiency and reduced work capacity: A critical review of the research to determine a causal relationship. J Nutr 2001; 131 (Suppl2): 676S-688S.
28. Davies KJ, Maguire JJ, Brooks GA, et al,: Muscle mitochondrial bioenergetics, oxygen supply, and work capacity during dietary iron deficiency and repletion. Am J Physiol 1982; 242: E418-E427. (Pubitemid 12050351)
29. Dong F, Zhang X, Culver B, et al,: Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: Involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond) 2005; 109: 277-286. (Pubitemid 41337132)
30. Cook JD,: Diagnosis and management of iron deficiency anaemia. Best Pract Res Clin Haemtol 2005; 18: 319-332. (Pubitemid 40298373)
31. Bolger AP, Bartlett F, Penston H, et al,: Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006; 48: 1225-1227. (Pubitemid 44345150)
32. Okonko DO, Grzeslo A, Witkowski T, et al,: Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008; 51: 103-112.
33. Toblli JE, Lombrana A, Duarte P, et al,: Intravenous iron reduces NT pro- brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007; 50: 1657-1665. (Pubitemid 47562670)
34. Usmanov RI, Zueva EB, Silverberg DS, et al,: Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol 2008; 21: 236-242.
35. Anker SD, Comin Colet J, Filippatos G, et al,: Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448.
36. Singh K, Fang YF,: Intravenous iron polymaltose complex for treatment of iron deficiency anaemia in pregnancy resistant to oral iron therapy. Eur J Haematol 2000; 64: 272-274. (Pubitemid 30186786)